Poster Abstract Session:
141. Clinical Practice Issues
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Adult ID, Epidemiology and Infection Control, Pediatric ID

Indications for Antibiotic Orders: How Accurate Are They?
Emily Heil, PharmD, BCPS-AQID; Lisa Pineles, MA; Daniel Morgan, MD, MS, FIDSA, FSHEA; Anthony D. Harris, MD, MPH; Kerri Thom, MD, MS
Fixed Versus Free-Text Documentation Of Indication For Antibiotic Orders
Waleed Javaid, MD; Shaelyn Cavanaugh, MPH; Christina Lupone, MPH; Telisa Stewart, DrPH; Tasaduq Fazili, MBBS; Benjamin White, MD
  • ID Week Poster - FInal2.pdf (1.4 MB)
  • Antibiotic prescription patterns for acute diarrhea in a hospital in Shanghai in 2016: a cross-sectional study
    Yanhong Hu, PhD M.D; Shanjuan Wang, M.D; Sunying Hua, M.D; Merlin Willcox, DPhil; Michael Moore, BM, BS, MRCP, FRCGP; Paul Little, MBBS, BA, MD, DLSHTM, MRCP, FRCGP, FMedSci
    Causal Conditions Supporting Antibiotic Stewardship Information Dashboards
    Jacob Kean, PhD; Jorie Butler, PhD; Lisa Bunker, MA; Matthew Goetz, MD; Peter Glassman, MBBS, MSc; Makoto Jones, MD, MS; Christopher Graber, MD, MPH, FIDSA; Karl Madaras-Kelly, PharmD, M.P.H.; Matthew Samore, MD, FSHEA; Charlene Weir, PhD
    Changing Pattern of Antibiotics Usage Among Hospitalized Patients of a Tertiary Hospital in South Korea: 2004-2013
    Bongyoung Kim, M.D. Ph.D.; Hyeonjun Hwang, M.S.; Myoung-Jae Lee, Ph.D; Jieun Kim, M.D, Ph.D; Hyunjoo Pai, M.D. Ph.D.
    Effectiveness of Antimicrobial Use and Diagnostic Testing in the Postoperative Setting for Colectomy, Craniectomy and Knee Arthroplasty
    Huma Saeed, M.D.; Jennifer Grant, MD; Eric Bhaimia, DO; Ronak Parikh, DO; Frances Lahrman, DO; Moira C. McNulty, MD; Ari Robicsek, MD; Rema Padman, PhD; Nirav Shah, MD, MPH
    Using Preventive Health Alerts in the Electronic Health Record Improves Testing Rates for Infants Perinatally-Exposed to Hepatitis C
    Leila Hojat, MD; Amrita Bhardwaj, MD; David Bar-Shain, MD; Peter Greco, MD; Nazha Abughali, MD
    Use of a Precision Antibiotic Therapy (PAT) Prediction Model to Identify Multidrug-Resistant (MDR) Enterobacteriaceae
    Alexandra Varga, PharmD; Leigh Cressman, MA; Ebbing Lautenbach, MD, MPH, MSCE; Valerie Cluzet, MD; Pam Tolomeo, MPH; Warren Bilker, PhD; Keith Hamilton, MD
    Joint consultation clinic by Infectious Diseases Specialists and Podiatry team (ID-POD) compliments the care of diabetic patients with foot infections by reducing cost and decreasing outpatient clinic visits
    Pushpalatha Bangalore Lingegowda, MBBS MD (INFECTIOUS DISEASES); Say-Tat Ooi, MD; Jyoti Somani, MD; Chelsea Law, MSc podiatry; Boon Kiak Yeo, BSc podiatry
    Opportunities in the Acute Care Setting for Infectious Diseases/Hospitalist Patient Co-Management
    Siddhi Gupta, DO; Amit Bansal, MD; Eric Newman, MD; Stanley Martin, MD
    Implementation of a Centralized Infectious Diseases Telehealth (IDt) Service for 16 Small Community Hospitals
    Todd J. Vento, MD, MPH; Stephanie S. Gelman, MD; John J. Veillette, PharmD; Mary A. Adams, RN, BSN; Katherine A. Repko, RN, MSN; Peter S. Jones, MSLS; Brandon J. Webb, MD; Kristin K. Dascomb, MD, PhD; Bert K. Lopansri, MD, FIDSA; Edward A. Stenehjem, MD, MSc
    2015-2016, Georgia Department of Public Health Districts, Evaluating Oral Health Services in Ryan White Part B Clinics
    Elizabeth Rabold, MD; Gregory Felzien, MD, AAHIVS; Michael Coker, MSN, RN, ACRN
    Potentially Inappropriate Durations of Anti-Infective Therapy at Hospital Discharge Despite Inpatient Antimicrobial Stewardship
    Neal Fox, BSPS; Lauren Haines, BSPS; Rachel Bull, BSPS; Zachary Jenkins, PharmD, BCPS; John Ballentine, PharmD; Steven Burdette, MD, FIDSA; Craig Pleiman, PharmD
  • ID Week Poster.pdf (803.9 kB)
  • Patient Self-Referral to Infectious Diseases Clinic: You Don’t Always Get What You Want, But Hopefully What You Need
    Katherine Holman, MD; Eric Wolske, BA; Demeatrice Nance, .; Jeff Olender, MBA; Kristin Englund, MD; Steven Gordon, MD
    Outpatient Parenteral Antimicrobial Therapy (OPAT) Practices at a Veterans Affairs Hospital: Potential for Pharmacist Impact
    Catherine Yang, Pharm.D.; Nancy N. Nguyen, Pharm.D., BCPS, AAHIVP, FCSHP; Aarthi Chary, MD; Trisha S. Nakasone, Pharm.D., BCPS AQ-ID
  • Poster 1087.pdf (441.9 kB)
  • Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population
    Lucinda J. Van Anglen, PharmD; Richard M. Mandel, MD, FIDSA; Ramesh V. Nathan, MD, FIDSA; Andrew H. Krinsky, MD; Quyen Luu, MD; Alfred E. Bacon, Iii, MD; H. Barry Baker, MD, FACP; Claudia P. Schroeder, PharmD, PhD; Kimberly A. Couch, PharmD, MA, FIDSA, FASHP
    Emergency Department Utilization during Self-Administered Outpatient Parenteral Antimicrobial Therapy
    Anisha Ganguly, B.S., B.A.; Larry Brown, MS, MPH; Deepak Agrawal, MD, MPH; Kavita Bhavan, MD, MHS
    Early ID Outpatient Follow-up of OPAT Patients Reduces 30-day Readmission
    Ena Saini, MD; Mohammad Ali, MD, MPH; Ping Du, MD, PhD; Tonya Crook, MD; John Zurlo, MD
    Pilot of a Home Telehealth Platform in a Pediatric OPAT Program
    Louise Vaz, MD, MPH; Tamara Wagner, MD; Bryan Cochran, BA*; Mark Lovgren, MBA
    Utilizing a Post-discharge Telephone Call in Outpatient Parenteral Antimicrobial Therapy (OPAT): Findings from a Quality Improvement Project
    Kimberly Felder, PA-C, MCR; Louise Vaz, MD, MPH; Penelope Barnes, MBBS, MRCP, FRCPATH, PhD; Cara Varley, MD, MPH
  • 9_19_17 Felder IDSA Poster.pdf (367.5 kB)
  • Emergency Department Visits during Outpatient Parenteral Antimicrobial Therapy: A Cohort Study
    So Lim Kim, BA; Angela Everett, AAS; Susan J. Rehm, MD, FIDSA; Steven Gordon, MD; Nabin Shrestha, MD, MPH, FIDSA, FSHEA
  • opat_ed_poster.pdf (495.8 kB)
  • Risk Factors for Readmission in Patients with Outpatient Parenteral Antimicrobial Therapy
    Victoria Huang, PharmD; Polina Lerner, PharmD, BCPS; Jorg Ruhe, MD, MPH; Marianna Fedorenko, PharmD, BCPS
    Impact of an Antimicrobial Stewardship Program Led OPAT Program on Clinical Complications and Frequency of Hospital Readmissions
    J. Andrew Carr, Pharm.D., BCPS (AQ-ID); John W. Baddley, MD; Sonya Heath, MD; Rachael A. Lee, MD; Todd P McCarty, MD
  • IDWeek 2017.Poster.Final.pdf (478.0 kB)
  • Characterization of Readmissions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program Over a Two-Year Period at UNC Medical Center
    Onyeka Nwankwo, MD; Anh Eichholz, PA-C; Vahini Chundi, MD; Alan Kinlaw, PhD; Tenesha Medlin, RN; Lisa Fletcher, PharmD; Wesley Kufel, PharmD; Claire Farel, MD, MPH; Ashley Marx, PharmD
    Predictive clinical rule for readmissions in OPAT. Improving in security
    Itsaso Bengoetxea, MD; Miren J. Onaindia, MD; Antonio Apezetxea, PhD; Montserrat Gomez, MD; Muskilda Goyeneche, MD; Magdalena Fernandez, MD; Begoña Vazquez, MD; Miriam Berroete, MD; Itziar Olarreaga, MD; Jose M. Quintana, MD, PhD; Urko Aguirre, BSST
  • sandiego1099.pdf (660.9 kB)
  • Stability of Anidulafungin in Concentrated Pharmaceutical Solution
    Chien Yap, B.Sc.(Pharm)(Hons); Chi Lui Ho, B.Pharm.(Hons), PhD.; Yin Shan Lim, B.Sc.(Pharm)(Hons).BCNSP; Siang Fei Yeoh, B.Pharm(Hons), M.Pharm, BCPS(Aq-ID) AP(Infectious Diseases)
  • FYP Poster CAA 03032017.pdf (661.3 kB)
  • Impact of obesity on acute kidney injury incidence among patients treated with piperacillin-tazobactam and vancomycin
    W. Cliff Rutter, PharmD, MS; Ronald Hall, PharmD, MSCS; David S. Burgess, PharmD, FCCP, FIDP
    A Little Bit of Dalba Goes a Long Way: Dalbavancin Use in a Vulnerable Patient Population
    Chloe Bryson-Cahn, MD; Alison Beieler, PA-C, MS; Jeannie Chan, PharmD, MPH; Steve Senter, BS; Robert Harrington, MD; Shireesha Dhanireddy, MD
  • Dalba IDWEEK Poster FINAL.pdf (536.9 kB)
  • Safety and Efficacy of Telavancin at an Outpatient Parenteral Antibiotic Therapy (OPAT) Unit in New York City
    George D. Rodriguez, Pharm.D.; Lorena Polo, M.D.; Carl Urban, PhD; Glenn Turett, MD; Nishant Prasad, MD; Nathan Warren, P.A.-C.; Demetra Tsapepas, PharmD, BCPS; Rabindra Ghimire, M.D.; Sorana Segal-Maurer, M.D.
    Pharmacist-Directed Use of Dalbavancin in Acute Bacterial Skin and Skin Structure Infections to Reduce Hospital Length of Stay
    Bruce Jones, PharmD, BCPS; Roby Hersey, PharmD; Joseph Crosby, PhD, RPh; Christopher Bland, PharmD, BCPS, FIDSA
    Experience with High Dose Once-daily Vancomycin for Patients with Skin and Soft Tissue Infections in an Ambulatory Setting
    Maggie Wong, PharmD; Michael G. Chapman, MD; Sangita Malhotra, MD; Yazdan Mirzanejad, MD; Gregory D. Deans, MD, MHSc
  • IDWeek Poster FINAL.pdf (410.0 kB)
  • Using Group-Based Trajectory Temperature Modeling to Predict Postoperative Infections after Total Knee Arthroplasty
    Jennifer Grant, MD; Moira C. Mcnulty, MD; Krista Kinnard, MS; Daniel Nagin, PhD; Ari Robicsek, MD; Ravi Bashyal, MD; Rema Padman, PhD; Nirav Shah, MD, MPH
  • JGrant_GBTM&TKA_IDWeek.pdf (2.6 MB)
  • Weighing in: Effect of BMI on postoperative fever and complications in patients undergoing three distinct surgeries
    Eric Bhaimia, D.O.; Moira C. McNulty, MD; Frances Lahrman, DO; Ronak Parikh, DO; Huma Saeed, M.D.; Ari Robicsek, MD; Rema Padman, PhD; Nirav Shah, MD, MPH; Jennifer Grant, MD
    Current Use of Intravenous (IV) Long Acting Antibiotic (LAA) Therapy in the Aetna Health Plan among Patients with Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
    Rajesh Mehta, RPh, MS; Alison Edwards, MStat; Katelyn R. Keyloun, PharmD, MS; Nicole Bonine, PhD, MPH; Iver Juster, MD
  • Healthagen(DAL17075.5313).pdf (347.9 kB)
  • Injection Drug Use and Infectious Disease Practice: A National Provider Survey
    Alison B. Rapoport, MD; Susan E. Beekmann, RN, MPH; Philip M. Polgreen, MD; Christopher F. Rowley, MD/MPH
    Implementation of a Standardized Protocol for Hospitalized Patients Who Inject Drugs and Require Long-Term Antibiotics Reduces Length of Stay Without Increasing 30-Day Readmissions
    Robert J. Rolfe Jr., MD; Ronnie E. Mathews, MD; J Martin Rodriguez, MD; Cayce S. Paddock, MD; Peter S. Lane, DO; Benjamin B. Taylor, MD; Rachael A. Lee, MD
  • IVATPoster.pdf (859.8 kB)
  • Systematic Review of Professional Liability when Prescribing Beta-Lactams for Patients with a Known Penicillin Allergy
    Meghan Jeffres, PharmD; Elizabeth Hall-Lipsy, JD, MPH; S. Travis King, PharmD, BCPS; John Cleary, PharmD
    Adverse Drug Reactions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program 2015-2016 at UNC Medical Center
    Vahini Chundi, MD; Anh Eichholz, PA-C; Onyeka Nwankwo, MD; Alan Kinlaw, PhD; Wesley Kufel, PharmD; Tenesha Medlin, RN; Lisa Fletcher, PharmD; Ashley Marx, PharmD; Claire Farel, MD, MPH
  • UNC OPAT ADR POSTER 1116.pdf (320.2 kB)
  • Variation in Reporting of Penicillin Allergy and its Consequences : an Evaluation of 13 Hospitals
    Florian Daragjati, PharmD, BCPS; David Silver, PharmD, BCPS; Roy Guharoy, PharmD, MBA; Clariecia Groves, MS; Danielle Sebastian, PharmD, BCPS; Mohamad Fakih, MD, MPH
  • Penicillin Poster-V4.pdf (205.2 kB)
  • Adverse Events Releated to Antibiotic Use in Patients with Myasthenia Gravis
    Kristen Zeitler, PharmD; Ripal Jariwala, PharmD; Jose Montero, MD, FACP, FIDSA

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.